1-5 October, 2019
The ENYO Pharma team will be present in Melbourne in October to present, in collaboration with Pr. André’s Inserm team, a poster entitled “Interplay and Recruitment of FXR and HBx on cccDNA and Role on Viral Transcription” describing FXR mechanism of action in HBV inhibition.
27th of Sept – 1st of Oct
ENYO Pharma will attend the ESMO conference in order to raise awareness of it novel, potent chemistry which induces Immunogenic Cell Death in multiple tumour types and inhibits tumor growth in animal models.
10-12 September, 2019
ENYO Pharma will attend the Nordic Life Science Partnering conference in Mälmo to present its projects, technologies and partnering opportunities. At the same conference, ENYO will also participate in a panel discussion hosted by Charles River where several companies will share their experiences on fee for service partnering in drug discovery.
11-12 July, 2019
ENYO Pharma was present in Paris during the NASH meeting to meet the other NASH actors and discuss with them about our last results.
24-25 juin 2019
ENYO Pharma team will be present in Paris from the 24th to the 25th of June to assist to the “Healthtech Investor days” a European business event. This will be the opportunity to meet investors and pharma companies.